3-Methyl-4-phenyl-6H-isoxazolo[3,4-d]pyridazin-7-one
ADVERTISEMENT
- Molecular formula
- C12H9N3O2
- CAS Number
- 16258-49-2
- IUPAC Name
- 3-methyl-4-phenyl-6H-isoxazolo[3,4-d]pyridazin-7-one
- Molecular Weight
- 213.22g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.2500g/cm3
- Synonyms
- 3-methyl-4-phenylisoxazolo[3, 4-d]pyridazin-7(6H)-one
Identification
Interesting facts
Interesting Facts about 3-methyl-4-phenyl-6H-isoxazolo[3,4-d]pyridazin-7-one
3-methyl-4-phenyl-6H-isoxazolo[3,4-d]pyridazin-7-one is a fascinating compound that piques the interest of chemists due to its unique structure and potential applications. Here are some captivating aspects of this compound:
- Structural Complexity: The compound features a heterocyclic structure, which is a defining characteristic of many biologically active molecules. Its isoxazole and pyridazine rings contribute to its intriguing chemical behavior.
- Pharmacological Potential: Research suggests that derivatives of this compound could exhibit significant antioxidant and anti-inflammatory properties, making them prospective candidates for further development in medicinal chemistry.
- Diverse Applications: Compounds with similar structures have been investigated for their applicability as drug leads in therapeutic areas such as neurodegenerative diseases and cancer treatment.
- Synthesis Challenges: The synthesis of 3-methyl-4-phenyl-6H-isoxazolo[3,4-d]pyridazin-7-one often involves sophisticated multi-step reactions, making it a great subject of study in synthetic organic chemistry.
- Analytical Techniques: To fully characterize this compound, chemists may employ various techniques such as Nuclear Magnetic Resonance (NMR), Mass Spectrometry (MS), and Infrared Spectroscopy (IR), showcasing the essential role of analytical chemistry in understanding complex molecules.
In summary, 3-methyl-4-phenyl-6H-isoxazolo[3,4-d]pyridazin-7-one serves as a prime example of the intersection of structure and function in organic compounds, highlighting the ongoing advancements in the field of pharmaceutical chemistry.